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Abstract: Increased levels of inflammatory markers such as tumour necrosis factor-α (TNFα) and inter- leukin-6 
(IL-6) have been associated with formation of new blood vessels, or angiogenesis, and linked to chronic 
inflammation in obesity. This study aimed to establish and use a versatile co-culture cell system to further 
investigate the role of TNFα and IL-6 in modulating (i) tubule formation and (ii) cell-cell interactions via matrix 
metalloproteinase (MMP) enzyme activity and secretion of vascular endothelial growth factor (VEGF), E-selectin 
and prostaglandin E2 (PGE2). Co-cultures of human endothelial cells and fibroblasts were incubated with TNFα 
(10 ng/mL) or IL-6 (10 ng/mL) added 2 and/or 7 days after co-culture establishment.  Cell viability by enzymatic 
conversion was determined by MTT assay; tubule formation was detected by immunostaining; VEGF, E-selectin 
and PGE2 expression by ELISA analysis and MMP enzyme activity by gel zymography. Treatment- specific and 
time dependent differences in tubule formation were observed: IL-6 significantly increased tubule formation, 
whilst TNFα significantly inhibited tubule formation. Treatment-specific differences in levels of MMP activities 
which correlate to tubule formation were also observed. This study showed inflammatory markers, typically 
associated with obese status, affect tubule formation differently in a heterogeneous cell environment similar to 
that observed in vivo. 
Keywords: Angiogenesis, co-culture, cytokines, fibroblasts, HUVEC, obesity. 
INTRODUCTION 
Inflammatory markers such as tumour necrosis factor-α (TNFα) [1], interleukin-6 (IL-6) [2], along with leptin [2] and 
hepatocyte growth factor (HGF) [3] have been shown to be elevated in plasma of obese individuals [4] and considered a 
major risk factor for the development of long term chronic conditions (e.g., cardiovascular disease, type 2 diabetes, stroke 
and cancer) [5, 6] and vascular complications [7]. As some of these inflammatory markers have been implicated in the 
increased development of angiogenesis [8- 11], it is very important to identify and characterise the role that such 
inflammatory markers have on modulating angio- genesis. 
Angiogenesis, or the growth of new blood vessels, is an important multi-step process, which occurs both in the 
maintenance of health and in certain disease states [12]. It plays a key role in normal vascular tissue development and repair 
(e.g., natural wound healing), but, when disease occurs, it can be deregulated and end in an abnormal increase of vessel 
density (e.g., tumourgenesis, diabetic retinopathy and atherosclerotic plaques) [13]. Additionally, angiogenesis plays a 
crucial role in the modulation of adipogenesis [14]. 
Angiogenesis involves an extensive interplay between a variety of growth factors, cytokines, enzymes and cells, together 
with extracellular matrix (ECM) components [13, 15, 16]. Vascular endothelial growth factor (VEGF) is a major angiogenic 
growth factor that stimulates proliferation and migration of endothelial cells (EC) [17] and is secreted by almost all solid 
tumours, tissue-infiltrating macrophages and host stromal cells [18]. Other important growth factors are basic fibroblast 
growth factor (b-FGF), HGF and angiopoietin (Ang)-1 and 2 [13]. These growth factors exert their biological activity on 
EC through various signalling pathways; where excess growth factors stimulate angiogenesis. Interestingly, many of the 
cytokines and growth factors responsible for angiogenesis are also regulators of tissue- degrading matrix metalloproteinase 
(MMP) enzymes [19]. 
MMP enzymes are a family of structurally related proteinases which are readily able to degrade all components of the 
ECM [20, 21]. The regulation of MMP activity is known to play a key role in EC migration during angiogenesis [22]. There 
is little or no basal production of MMP enzymes in most cell types. However, MMP expression and activity are inducible: 
with regulators known to include growth factors, cytokines and cell-matrix interactions, and their role in cancer has been 
implicated in tumour invasion and metastasis [21]. More specifically, MMP-2 (Gelatinase A, 72 kDa) and MMP-9 
(Gelatinase B, 92 kDa), which degrade denatured collagens and basement membrane components, have been 
associated with this process [21]. MMP-2 is typically produced in most human tissue cell types and, interestingly, elevated 
levels of MMP-2 are associated with invasive behaviour [23]. 
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These include monoculture assays (such as motility assays, matrigel formation or proliferation assays) or organ and tissue-
specific assays (such as cornea assay or the chick chorioallantoic membrane (CAM) assay) [24]. However, the co-culture 
assay system established by Bishop and colleagues [15], in which primary human EC and primary normal human dermal 
fibroblasts are grown together, overcomes the limitations of the former assays and, in particular, can be used to observe the 
generation and growth of endothelial tubules, as well as inhibition, within a heterogeneous cellular environment [24]. In 
this study, the co-culture system established by Bishop et al. [15] has been further developed to create a more versatile 
system which allows the additional study of the correlation between specific inflammatory markers and vessel formation 
and progression. 
The present study aimed to use this more versatile in vitro co-culture system to determine the role of TNFα and IL-6 – 
two highly elevated pro-inflammatory cytokines, typically associated to the obese status – in modulating (i) tubule 
formation and (ii) cell-cell interactions via MMP enzyme activity and secretion of VEGF, E-selectin and PGE2. 
Using the versatile co-culture assay model, treatment- specific and time-dependent differences in tubule formation were 
observed; IL-6 significantly increased tubule formation, whilst TNFα significantly inhibited it. Moreover, treatment specific 
differences in levels of MMP enzyme activities - which influence tubule formation - were observed. These results add 
further knowledge to the understanding of the role of inflammatory markers, commonly associated to the obese status, in 
modulating angiogenesis. 
MATERIALS AND METHODS 
Materials 
All chemicals and cell culture reagents were purchased from Sigma-Aldrich Ltd (UK) unless otherwise stated. 
Cell Culture 
Primary human umbilical vein endothelial cells (HUVEC) and primary normal human dermal fibroblasts (NHDF) were 
obtained from Clonetics (Lonza, UK). HUVEC were maintained in endothelial basal medium (EBM-2; Clonetics, Lonza, 
UK) supplemented with EGM-2 SingleQuots (Clonetics, Lonza, UK) (i.e., EGM-2 medium) whilst NHDF were 
maintained in fibroblast basal medium (FBM; Clonetics, Lonza, UK) supplemented with FGM-2 Single- Quots 
(Clonetics, Lonza, UK) (i.e., FGM-2 medium). 
The EC/fibroblast co-culture system was set up using HUVEC (between passages 1-8) and NHDF (between passages 
1-12) following the protocol established by Bishop and colleagues [15]. HUVEC and NHDF were mixed and seeded in 24 
well plates (Thermo Fisher Scientific Nunc, UK) in EGM-2 medium. Co-cultured cells were incubated for up to 14 days at 
37°C in a 5% CO2 in air humidified incubator.
The co-culture system was manipulated and tested by removing VEGF from the EGM-2 medium (EGM-2Ө: EGM-2 
medium minus the SingleQuot of VEGF) and by adding exogenous VEGF (50 ng/mL) and/or anti- VEGF (50 ng/mL). 
Cell Viability by Enzymatic Conversion 
HUVEC and NHDF (1x105 cells/mL) were incubated with different concentrations of TNFα or IL-6 (100 µL/well; 96 
hours) in EGM-2 and FGM-2 medium, respectively. Cell viability was evaluated by MTT ((3-(4, 5-dimethyl-thiazol-2-
yl)-2, 5-diphenyltetrazolium bromide) assay [25]. Absorbance was read at 560 nm in a plate reader (Bio-Tek, UK). 
Co-culture Treatment 
The co-culture system was incubated with EGM-2 medium to initiate tubule formation and, 2 and/or 7 days after co-
culture establishment, medium was changed to EGM-2Ɵ (i.e., EGM-2 medium minus VEGF SingleQuot), EGM-2Ө 
supplemented with 10 ng/mL TNFα (EGM-2Ө+TNFα) or EGM-2Ө supplemented with 10 ng/mL IL-6 (EGM-2Ө+IL- 6). 
The medium was collected every 4 days and replaced with respective treatments. Collected medium was stored at -20°C 
until use. 
The expression of secreted VEGF (DuoSetELISA, R&D Systems, Cat# DY293B), human E-selectin/CD62E (DuoSet 
ELISA, R&D Systems, Cat# DY724) and human prosta- glandin E2 (PGE2: Parameter ELISA, R&D Systems, Cat# 
KGE0004B) in the collected media were measured according to manufacturer’ instructions. These assays have a sensitivity 
of approximately 30 pg/mL and quantify both the natural and recombinant forms of each protein. 
Immunostaining 
After 14 days, co-cultures were fixed at room temperature with ice-cold 70% (v/v) ethanol and stained with myeloma 
cell adhesion molecule (MCAM (CD146); specific to HUVEC) or collagen type IV to assess the extent of tubule formation. 
MCAM allowed the visualisation of tubule formation and growth and was detected with monoclonal mouse anti-human 
MCAM antibody (R&D Systems, USA) with the secondary goat anti-mouse IgG (whole antibody) conjugated with 
alkaline phosphatase. Sigma FAST 5-bromo-4-chloro- 3-indolyl phosphate/nitro blue tetrazolium (BCIP/NBT) was the 
substrate with the reaction yielding a dark purple end product. The co-cultures were dried overnight at room temperature 
Several in vitro and in vivo methods have been established over the years to study the factors that influence angiogenesis. 
and analysed. Collagen type IV was used to visualise the presence of lumen. A monoclonal mouse anti-human collagen 
type IV antibody was used with the same secondary and substrate as before. 
Co-cultures were viewed using an Olympus 1XS1 microscope with Olympus TL4 light box. The image software used 
was Infinity Capture Application Version 5.0.0 (Lumenera Corporation, Canada) with camera model Infinity 2-2c. Three 
images per well were captured and saved as BMP images of 1616 x 1216 pixels. Illumination was set to give a best contrast 
between stained tubules and unstained fibro- blasts. Tubule formation was defined by total tubule length and quantification 
was achieved by AngioSys® software Version 1.0 (TCS Cell Works, UK). 
Gel Zymography 
For the analysis of MMP-2 and MMP-9 enzyme activity, the medium was collected from 3 separate experiments and 
quantification of the total protein secreted carried out by the Bradford protein assay, according to manufacturer’s 
instructions. MMP enzyme activity was assessed in relation to tubule formation at the end of co-culture incubation by gel 
zymography adapted from Connelly and colleagues [22]. Briefly, equal volumes of samples were loaded onto a 10% SDS-
polyacrylamide gel containing 0.1% (v/v) porcine gelatin. After electrophoresis, to remove the SDS, the gels were washed 
twice for 15 minutes each in 2.5% (v/v) Triton X-100 and then incubated overnight at 37°C in substrate buffer (50 mM 
Tris-HCl, pH 7.6 and 10 mM CaCl2) in the absence and presence of 10 mM EDTA. Gels were stained for 40 minutes with 
two changes of 0.5% Coomassie Blue R-250 (ICN Biomedical, USA), destained twice for 20 minutes in 50% (v/v) 
methanol, 10% (v/v) acetic acid and dried (Dry Ease Mini Gel drying system, Invitrogen, UK). MMP enzymes were 
visualised with areas of gelatinolytic activity which appear to be clear against the dark background of the stained gel. MMP 
enzymes were analysed using Image J 1.43u software (NIH, USA) and a Kaleidoscope Precision Plus Protein Standard 
(Bio-Rad, UK) was used to determine the molecular weight of each MMP band. 
Statistical Analysis 
Unless otherwise stated, all data are expressed as mean ± SEM of three independent experiments from different cell 
passage numbers. Statistical differences were determined by unpaired t-test (Graphpad Prism) or by one-way analysis of 
variance (ANOVA) with Dunnett’s multiple comparison t-test (Graphpad Prism). P<0.05 was considered to be statistically 
significant. 
RESULTS 
Effect of TNFα or IL-6 on Cell Viability 
Cell viability in HUVEC and NHDF was quantified by MTT assay where mitochondrial activity is assumed to reflect 
the rate of cell metabolism and, thus, the rate of enzymatic conversion is directly representative of cell viability. The cells 
were incubated with different concentrations (0.01-200 ng/mL) of TNFα or IL-6 for 96 hours (Fig. 1). The percentage cell 
viability was normalised to the corresponding untreated control (i.e., PBS for TNFα or H2O for IL-6). 
No change to cell viability, compared to the control, was observed between 0.01-10 ng/mL TNFα in HUVEC, but cell 
viability was significantly decreased with 100 and 200 ng/mL TNFα; by 25 and 18%, respectively (Fig. 1A). In- creased 
cell viability, compared to the control, was observed between 0.01-1 ng/mL TNFα in NHDF with a significant increase of 
119, 112 and 107% with 10, 100 and 200 ng/mL TNFα, respectively (Fig. 1B). No change to cell viability, compared to the 
control, was observed with 0.01-200 ng/mL IL-6 in either HUVEC (Fig. 1A) or NHDF (Fig. 1B). Thus, 10 ng/mL was 
chosen for both cytokines to be used for tubule formation experiments. 
Versatility of the Co-Culture System Used 
MCAM and collagen type IV staining were used throughout this study to assess tubule formation and growth (Fig. 2A), 
together with quantification of total tubule length using AngioSys software analysis. The formation of tubules mimicking 
the process of angiogenesis was observed, over 14 days, and structures resembling a microvasculature bed developed (Fig. 
2B). The co-culture system was manipulated to test its dependence from the content of VEGF in the medium by incubating 
the co-culture in EGM-2Ө and either adding exogenous VEGF (50 ng/mL)  and/or  anti-VEGF (50 ng/mL) (Fig. 2C). The 
extent of tubule formation observed in the different culture conditions (Fig. 2) highlights the versatility and usability of this 
system. Tubule formation obtained from cells co-cultured in EGM-2 medium was chosen as a positive control throughout 
this study. 
Fig. (1). Effect of TNFα or IL-6 on (A) HUVEC and (B) NHDF viability. Cell viability was determined using MTT assay after 96 hours.  
Data are mean ± SEM of 3 independent experiments; each experiment consisted of 4 replicates per concentration; *P<0.05, **P<0.01, 
***P<0.001. Note changes to the % cell viability scale (i.e., y axis). 
Effect of TNFα or IL-6 on Tubule Formation 
The effect of TNFα or IL-6 on tubule formation was tested with EGM-2Ө medium in order to examine tubule formation 
in the absence of VEGF. Co-cultures were initially incubated in EGM-2 medium (Day 0) and, after establishment, EGM-
2Ө, EGM-2Ө+TNFα or EGM-2Ө+IL-6 were added after 2 and/or 7 days (Fig. 3). These conditions were used to assess the 
ability of these cytokines to respectively (i) promote/prevent tubule formation, or (ii) increase/reduce tubule formation once 
the process has already started. 
Tubules were clearly formed and visualised after 14 days (Fig. 3A) and similar results were obtained in each experiment. 
The extent of tubule formation was quantified by measuring total tubule length and percentage change was normalised to 
the control (i.e., EGM-2Ө) (Fig. 3B). Tubule formation was significantly increased (43% increase) in EGM-2 medium 
incubated co-cultures compared to control co-cultures. TNFα significantly prevented tubule formation by 95% when added 
on day 2 and significantly reduced tubule formation by 59% when added on day 7 compared to control co-cultures. 
Incubating co-cultures with IL-6 significantly promoted tubule formation by 46% when added on day 2 compared to control 
co-cultures. Whilst tubule formation was further increased by 57% when added on day 7 compared to control co-cultures, 
this was not statistically significant. 
These results indicate TNFα and IL-6 altered several in vitro cell activities that are relevant to angiogenesis as 
expected, including cell viability and tubule formation. 
Fig. (2). (A) Tubule formation and growth assessed with MCAM and Collagen type IV staining of a typical co-culture on day 14. (B) Tubule 
formation over time (3 – 14 days) assessed by MCAM staining. (C) Tubule formation and growth assessed with MCAM staining at day 14 in 
co-cultures grown in EGM-2Ө, EGM-2Ө + 50 ng/mL VEGF, EGM-2Ө + 50 ng/mL VEGF + 50 ng/mL anti-VEGF and EGM-2Ө + 50 ng/mL 
anti-VEGF added on day 0. Medium was changed every 4 days. Each image is representative of 3 independent experiments; within an ex- 
periment, each treatment was carried out in duplicate and observed in three randomly chosen fields. Magnification 40x. 
Fig. (3). (A) Tubule formation and growth assessed with MCAM staining at day 14 in co-cultures grown in EGM-2Ө and EGM-2 (added 
on day 2), and EGM-2Ө+TNFα (10 ng/mL) or EGM-2Ө+IL-6 (10 ng/mL) added on day 2 or 7 after co-culture establishment, respectively. 
Medium was changed every 4 days. Images presented are representative of treatments from 3 independent experiments; within an 
experiment, each treatment was carried out in duplicate and observed in three randomly chosen fields. Magnification 40x. (B) 
Quantification of total tubule length determined using AngioSys software. Cytokines added on day 2 (black bars) and day 7 (white bars). 
Results are presented as a percentage of EGM-2Ө as mean ± SEM of 3 independent experiments; within each experiment, each treatment 
was carried out in duplicate; *P<0.05, **P<0.01, ***P<0.001. 
Measurement of VEGF, E-selectin and PGE2 Production from HUVEC/NHDF Co-cultures 
The effect of TNFα or IL-6 in vitro was evaluated in rela- tion to the production of the well-characterised angiogenic 
factor and signalling factor for malignant progression, VEGF, of the adhesion molecule E-selectin and of the 
protumourigenic prostanoid PGE2 which are markers of inflammation (Fig. 4). VEGF, E-selectin and PGE2 levels were 
measured by ELISA, in the medium collected from HUVEC/NHDF co-cultures cultured over 14 days, in EGM-2 
medium, EGM-2Ө, EGM-2Ө+TNFα or EGM-2Ө+IL-6 (Fig.4). Conditioned medium was collected after 2, 7 and 14 
days for EGM-2 medium and EGM-2Ө incubated co-cultures and for EGM-2Ө+TNFα or EGM-2Ө+IL-6 incubated co-
cultures on days 7 and 14. Results are presented as percentage change from the control (i.e., EGM-2Ө) on day 14. 
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Firstly, measurement of VEGF levels revealed no significant changes in medium collected on day 14, from co- cultures 
incubated with EGM-2 medium or EGM-2Ө+IL-6 compared to control (Fig. 4A). This result suggests that VEGF is utilised 
for tubule development in this co-culture system and does not accumulate in the conditioned medium. Medium collected 
from EGM-2Ө+TNFα incubated co- cultures contained higher VEGF levels (50% and 72% increase when TNFα was added 
after 2 and 7 days, respectively) than in the control. A statistically significant increase in VEGF was observed when TNFα 
was added on day 7 (and collected on day 14) (Fig. 4A). The increased levels of VEGF in medium collected from TNFα 
treated co-cultures mirror the decrease in total tubule length (Fig. 3B). Secondly, results obtained from E-selectin 
measurement show no significant changes in E-selectin expression, except for a significant increase (508%) in E-selectin 
expression with TNFα on day 7 (added on day 2) compared to control (Fig. 4B). Finally, measurement of PGE2 shows that 
there were no significant effects on PGE2 secretion, irrespective of treatment, when compared to control, except for when 
co- cultures were incubated with EGM-2 medium (20% de- crease) or EGM-2Ө+IL-6 (24% decrease) added on day 2 (and 
collected on day 14) (Fig. 4C). 
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Fig. (4). Changes in (A) VEGF expression (%) detected by a DuoSet human ELISA kit, (B) E-selectin expression (%) detected by a DuoSet 
human ELISA kit, and (C) PGE2 expression (%) detected by a Parameter human ELISA kit in the medium of HUVEC/NHDF co-cultures 
cultured, over 14 days, in  EGM-2Ө,  EGM-2  (positive  control  for  tubule  formation),  EGM-2Ө+TNFα  (10  ng/mL)  or  EGM-2Ө+IL-6 (10 
ng/mL). Results are presented as a percentage of EGM-2Ө as mean ± SEM of 3 independent experiments; within each experiment, each treatment 
was carried out in duplicate; *P<0.05, **P<0.01. Note the changes to the % expression scale (i.e., y axis). 
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Effect of TNFα or IL-6 on MMP Enzyme Activity 
To analyse if modulation of angiogenesis by TNFα or IL-6 was associated to changes in the enzyme activity of proteases 
involved in matrix remodelling, MMP-2 and MMP-9 enzyme activity were measured by gel zymography. Medium from 
HUVEC and NHDF grown individually or in combination, as HUVEC/NHDF co-cultures, was assayed as described in 
Materials and Methods. The activity of MMP enzymes was visualised as areas of gelatinolytic enzyme activity which appear 
clear against the dark background of Coomassie Blue stained gels. Gels were analysed using Image J software and the 
molecular weight of each MMP band determined; 92 kDa for MMP-9, 72 kDa for pro-MMP-2 (inactive pro-enzyme) and 
62 kDa for active-MMP-2 (cleaved, activated enzyme). No bands were detected in control gels incubated in the presence 
of EDTA (data not shown). 
The activity of MMP enzymes was initially determined in the medium of HUVEC and NHDF individually (Fig. 5). Cell 
culture medium was collected on days 2, 7, 10 and 14 after culture establishment and results show only pro-MMP-2 (inactive 
form) (Fig. 5A). Pro-MMP-2 activity was quantified and a statistically significant increase in pro-MMP-2 activity was 
observed in a time-dependent manner in both NHDF and HUVEC. Activity increased by 5- and 8-fold at day 7 and 10 of 
co-culture, respectively, in NHDF compared to activity at day 2. No further statistically different increase was observed at 
day 14. Similarly, activity increased by 8- and 11-fold respectively, in HUVEC compared to activity on day 2, with no 
further increase observed at day 14. 
MMP-9 and active-MMP-2 were not detected in NHDF and HUVEC when cultured individually (Fig. 5), however, in 
co-culture (medium collected at final end point - day 14), these MMP enzymes could be detected using gel zymography 
(Fig. 6A). The results show pro-MMP-2 activity was higher than active-MMP-2 activity when tubules were formed in 
control (i.e., EGM-2Ө) incubated co-cultures and in co-cultures grown with EGM-2 medium (statistically significant 
difference, P<0.05) or EGM-2Ө+IL-6 (Fig. 6B and C), with the exception of co-cultures incubated with EGM-2Ө+TNFα 
on day 2 and 7 when tubules were not formed (statistically significant difference (P<0.05) when TNFα added on day 7, but 
not when added on day 2) (Fig. 6B and C). Similar levels of pro-MMP-2 were observed irrespective of treatment. Active-
MMP-2 activity increased in EGM-2Ө+TNFα treated co-cultures (no tubules) compared to control co-cultures but this was 
not statistically significant. This trend was similar for treatments added on day 2 or day 7. No MMP-9 activity was found 
in any of these samples. However, in TNFα treated co-cultures, significantly higher levels of MMP-2 (i.e., active-MMP-2 
when TNFα was added on day 7) and MMP-9 activity (when TNFα was added on day 2 and day 7) were seen compared to 
control (Fig. 6B and C). Interestingly, MMP-9 activity correlated with absence of tubules, whilst MMP-2 activity 
corresponds to the presence of tubules (Fig. 3A and B). Activation of MMP-2 (i.e., ratio between active over pro-form) was 
differ- ently regulated in co-cultures grown in EGM-2 medium or EGM-2Ө compared to co-cultures treated with IL-6 or 
TNFα. A ratio <1, observed in cells grown in EGM-2 medium, EGM-2Ө and EGM-2Ө+IL-6, correlated with tubule 
formation whereas a ratio >1 observed in cells grown in EGM-2Ө+TNFα resulted in little or no tubule formation. This result 
suggests that, according to the treatments investigated in this study, a correlation exists between tubule formation and MMP 
enzyme activity: tubules may partly be produced by modulating the activity of different MMP enzymes. Because it is 
possible MMP enzyme activity changed in function of total protein secretion which in turn could alter tubule formation, the 
concentration of total protein secreted into the medium (from HUVEC and NHDF cultured individually or in co-culture) 
was determined using the Bradford protein assay. There were, however, no differences in the concentration of total protein 
secreted between any of the test conditions and time points (data not shown). 
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Fig. (6). (A) MMP-9, pro-MMP-2 and active-MMP-2 activity in HUVEC/NHDF co-cultures cultured, over 14 days, in EGM-2Ө, 
EGM-2 (positive control for tubule formation), EGM-2Ө+TNFα (10 ng/mL) or EGM-2Ө+IL-6 (10 ng/mL). MMP enzymes released 
from the co- culture into the medium on day 14 was collected and analysed by gel zymography. Images presented are representative 
of 3 independent experiments. Quantification of MMP activity in medium with treatments (B) added on Day 2 and (C) added on Day 
7 using Image J soft- ware. Results are presented as mean ± SEM of 3 independent experiments; *P<0.05, **P<0.01, ***P<0.001. 
DISCUSSION 
In this study, the effects of two inflammatory cytokines, TNFα and IL-6 were investigated. Experiments included 
assessing cell viability, tubule formation, secretion of VEGF, E-selectin and PGE2, and MMP enzyme activity using a more 
versatile in vitro HUVEC/NHDF co-culture system compared to the one developed by Bishop et al. [15]. This system has 
been established appositely and characterised (Fig. 2) to allow in depth studies of the role of specific molecules in 
modulating angiogenesis in addition to the heterogeneous cellular environment formed. 
This study showed that both HUVEC and NHDF were more responsive to TNFα than IL-6; indicating that TNFα 
induced greater changes to cell viability than IL-6. Additionally, TNFα significantly decreased the formation of tubules. 
In contrast, and similar to the results observed in co-cultures grown in EGM-2 medium, IL-6 significantly increased 
tubule formation. TNFα completely prevented formation of tubules when added on day 2 and stopped any further 
development of tubule formation once the process had already started as evident when added on day 7. IL-6, on the 
contrary, promoted the formation of tubules when added on day 2 and increased tubule formation once the process had 
already started as evident when added on day 7. These observations on tubule formation further indicate that angiogenesis 
is modulated by specific inflammatory markers. Additionally, this study has highlighted the importance of considering 
the time after tubule initiation when observing the generation and growth of endothelial tubules. This is the first time that 
a time course after initial tubule formation has been investigated and reported in the literature. Limited reports are available 
on the effect of TNFα or IL-6 alone in an in vitro co-culture cell system, except for a study conducted by Hashizume and 
colleagues [26]. Their study used fibroblast-like synovial cells from rheumatoid arthritis patients and HUVEC co-cultures 
to examine the effect of TNFα or IL-6 on tubule formation over 21 days; neither TNFα nor IL-6 induced tubule formation. 
Hashi- zume and colleagues [26] measured the final outcome (i.e., tubule formation after 21 days co-culture) and did 
not differentiate between promoting/preventing or increasing/reducing angiogenesis which was examined in this study. 
Furthermore, secretion of key angio- genic/tumourigenic factors and re-modelling of ECM via MMP activity has not been 
fully investigated previously in relation to TNFα or IL-6. These factors have been investigated in more detail in this work 
in order to improve the understanding of the role of cytokines in modulating angiogenesis. 
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It is well known that VEGF is one of the most important factors for accelerating angiogenesis [17]. In order to determine 
the relationship between tubule formation and release of VEGF, the concentration of VEGF secreted into conditioned 
medium was investigated using ELISA. Results revealed that co-culture treatment with TNFα induced an in- crease in 
secretion or accumulation of VEGF in the medium compared to co-cultures grown in EGM-2Ө and the increase in 
concentration paralleled the lack of tubules formed. These observations support previous studies which emphasise the key 
role and requirement of VEGF in new tubule formation [27]. 
During inflammation, EC are activated by inflammatory cytokines, such as TNFα, interleukin-1 (IL-1) and interferon γ 
(IFNγ), which induce up-regulation of adhesion molecules expression including E-selectin [28]. E-selectin (CD62E) is an 
EC-specific adhesion molecule involved in initial vessel wall binding [29]. Although expression of E- selectin has been 
previously described in single-cell conditions [30], insight into the regulation of E-selectin expression and endothelial 
functioning following incubation with inflammatory cytokines remains, to the best of our knowledge, to be determined in 
an in vitro EC/fibroblast co- culture system. 
Results in this study revealed no change in E-selectin expression, except for co-cultures grown in EGM- 2Ɵ+TNFα. 
This may suggest that the time points selected for medium analysis (collected on days 2, 7 or 14 after initial establishment 
of the HUVEC/NHDF co-culture system) were not ideal to observe any changes in E-selectin expression with EGM-2, 
EGM-2Ɵ or EGM-2Ɵ+IL-6; especially since this is an early event in angiogenesis. Previous studies have shown time-
dependent up-regulation of E-selectin expression, observed by immunofluorescence, in HUVEC activated with TNFα (4 
ng/mL) [28]. Griffioen and colleagues [28] also observed up-regulation of E-selectin ex- pression by IL-1α and IFNγ. 
Similarly, Mason and colleagues [31] observed E-selectin up-regulation, via surface and mRNA expression, in HUVEC 
stimulated with TNFα (10 ng/mL). The results presented in this study have shown, for the first time, that cells grown in 
a co-culture system (HUVEC/NHDF) also increased E-selectin expression when stimulated with TNFα. Also, as E-
selectin mRNA expression is barely detectable in unstimulated HUVEC [31]; it is not unsurprising that E-selectin 
expression was only observed in co-cultures treated with EGM-2Ɵ+TNFα because TNFα itself will further induce 
inflammation. Furthermore, it has been shown that angiogenic growth factors (e.g., bFGF and VEGF) suppress 
inflammatory cytokine- induced up-regulation of E-selectin, as well as intercellular adhesion molecule-1 (ICAM-1) and 
vascular cell adhesion molecule-1 (VCAM-1) [28, 32]. In the experimental set-up used in this study, the EC/fibroblast 
co-culture system is grown in the recommended endothelial growth medium (EGM-2) which contains a mixture of growth 
factors, including bFGF and VEGF, which may influence the observed responses. 
The protumourigenic prostanoid PGE2 is involved in promotion of angiogenesis [33, 34] and its production is known to 
be activated by inflammatory cytokines (IL-1β, IL-6 or TNFα) [35]. Similar to E-selectin, PGE2 secretion has been 
previously described in single-cell conditions in relation to angiogenesis [36], but, to our knowledge, its production remains 
to be determined in an in vitro EC/fibroblast co-culture system. Based on this information, our focus was driven by the 
assumption that the effect of TNFα or IL-6 on tubule formation could be mediated by PGE2 production. Results from this 
study showed that the presence of tubules (incubation with EGM-2 medium and EGM-2Ɵ+IL-6) de- creased PGE2 secretion, 
whilst the absence of tubules (incubation with EGM-2Ɵ+TNFα) did not change PGE2 production compared to the control. 
Therefore, secretion of PGE2 was not evident in the medium collected on day 14 from the co-culture system. PGE2 is (i) 
rapidly released in response to inflammation [37], (ii) responsible for stimulation of EC migration and proliferation [38, 39] 
and, therefore, (iii) an important early event in angiogenesis, which confers that the time point selected for analysis of PGE2 
secretion (collected on day 14 after initial establishment of HUVEC/NHDF co- culture system) was limiting to observe any 
changes in production. However, the findings presented do give new insight into the role of PGE2 or lack thereof in tubule 
formation. 
An initial step in the angiogenic process is degradation of the ECM [20, 21]. Following matrix breakdown, EC migrate 
and proliferate to form new vessels. Therefore, proteolytic enzyme activity, which degrades all components of the ECM, 
is essential for the initial process of angiogenesis and is performed by MMP enzymes [20, 21]. At present, regulation of 
MMP activity and the balance between MMP enzymes and their major inhibitors, Tissue Inhibitor of Metalloproteinases 
(TIMP) play a key role in EC migration and proliferation during angiogenesis [22, 40]. Given the important role of MMP 
enzymes in angiogenesis, the enzyme activity of MMP-2 and MMP-9 was measured in the media of HUVEC and NHDF 
individually and at the end point of co-culture incubation (day 14) in order to correlate enzyme activity to tubule formation 
using the widely accepted method of gel zymography. Untreated HUVEC and NHDF did not produce detectable MMP-
9. The pro-form of MMP-2 (72 kDa) was, however, visible in HUVEC and NHDF in this study. This data are in agreement
with previous gel zymography studies reported in the literature: Jiang and colleagues [41] and Oak and colleagues [27]
found only pro-MMP-2 expression in medium collected from cultured HUVEC, whilst Mauro and colleagues [42]
detected the expression of pro-MMP-2 and MMP-9 in conditioned medium from cultured HUVEC. However, this was
in contrast to what was observed in here, but the different medium used by Mauro et al. [42] could be responsible.
Additionally, literature searches have shown little or no information is available for the enzyme activity of MMP-2 or
MMP-9 in NHDF.
This study provides the first evidence that inflammatory markers can alter tubule formation in relation to the 
production and activity of MMP enzymes observed, at a final end point, in a heterogeneous cellular environment. 
Secretion of MMP-9 and activation of MMP-2 correlated with an absence of tubules, whilst the opposite was observed 
with the presence of tubules. In detail, treatment with TNFα resulted in MMP-9 production and activation of MMP-2 
(62 kDa). There is evidence to suggest that TNFα may be crucial in MMP production, in fact, it is known  
that TNFα (10 ng/mL) stimulates MMP-9 expression via activation of ERK1/2 in HK-2 proximal tubular cells [43] or 
via activation of NFκB in monocytes [44]. It remains to be seen whether these mechanisms are responsible for MMP-
9 production in this co-culture system and the investigation of the mechanisms by which MMP-9 expression is induced 
in the absence of tubule formation is currently on-going. 
Additionally, the role of MMP enzymes in obesity associated inflammation still remains unclear, but a recent study by 
Miksztowicz and colleagues [45] found increased plasma activity of pro-MMP-2 in overweight/obese women (BMI 25-
38.5 kg/m2, n=26) compared to normal weight women (BMI 18-24.9 kg/m2, n=13). Although these authors did not 
determine the origin of the measured pro-MMP-2, it is typically produced in most human tissue cell types, including adipose 
tissue. Interestingly, elevated levels of MMP-2 are associated with invasive behaviour [23] and findings reported here 
showed that pro-MMP-2 activity was higher than active-MMP-2 activity in co-cultures in the presence of tubules. Therefore, 
MMP-2 could be a key factor in angiogenesis and play an important role in tubule formation and cell-cell interactions. 
The versatile co-culture model which utilised primary HUVEC co-cultured with primary NHDF was used to study 
the role of two cytokines, TNFα or IL-6, typically associ- ated with obese status in modulating new blood vessel formation 
in vitro. EC become organised amongst the fibro- blasts as corded structures which proliferate, thicken and lengthen 
through the cell matrix to form an intricate net- work of tubule structures over 14 days which are well established features 
[15]. Although studies have reported similar conclusions for TNFα [46-48] and IL-6 [49-51] in single cells to the one 
presented, the further development of the co-culture model by Bishop and colleagues [15] allowed a more versatile and 
flexible approach to investigate angiogenesis, and its progression, relative to single cell studies. This study has further 
characterised, from a technical point of view, this in vitro co-culture system especially in relation to manipulation of 
medium components and time of addition (after 2 days vs 7 days) of key inflammatory markers. Finally, this study has 
enabled us to reach a stage where the system can be manipulated according to specific requirements and allows a more 
detailed understanding of the role of inflammatory cytokines in the development of new blood vessels in direct relation 
to MMP activity and secretion of key angiogenic markers. Interestingly, the concentrations of cytokines used in the study 
have been shown by Bermano’s group to play a role in the link between obesity and breast cancer [52] and this work will 
be taken forward in the context of obesity, breast cancer and angiogenesis ex vivo and in vivo. 
CONCLUSIONS 
In summary, this observational study showed treatment- specific differences in the regulation of angiogenesis and 
MMP activity. These findings show that it is critical to further improve understanding of how inflammatory cytokines 
can specifically contribute to the development of vascular complications in chronic inflammatory conditions such as the 
ones associated to obesity. In light of this, investigations in the effect of plasma from obese versus non-obese individuals 
using this versatile EC/fibroblast co-culture system are currently being explored. 
LIST OF ABBREVIATIONS 
EC 
ECM 
HUVEC 
= 
= 
= 
Endothelial cells Extracellular matrix 
Human umbilical vein endothelial 
cells 
IL-6 = Interleukin-6 
MMP = Matrix metalloproteinases 
NHDF = Normal human dermal fibroblasts 
PGE2 = Prostaglandin E2 
TNFα = Tumour necrosis factor-α 
VEGF = Vascular endothelial growth factor 
Coding for the different types of medium used: Endothelial basal medium (EBM-2) supplemented with SingleQuots 
(EGM-2 medium); EGM-2 medium minus the SingleQuot of VEGF (EGM-2Ɵ); EGM-2 medium minus the SingleQuot of 
VEGF supplemented with TNFα (10 ng/mL) (EGM- 2Ɵ+TNFα); EGM-2 medium minus the SingleQuot of VEGF 
supplemented with IL-6 (10 ng/mL) (EGM-2Ɵ+IL-6). 
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